Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Charlie Bilello slams "absurd" gov't data claiming health insurance fell 18%. He says costs "only go in one dir...
UBS analyst Kevin Caliendo maintains CVS Health (NYSE:CVS) with a Buy and raises the price target from $79 to $96.
Trump and EMD Serono strike a deal to cut fertility drug costs, expand U.S. manufacturing, and launch the TrumpRx Fertility pro...
CVS Specialty Pharmacy will be a core partner in the TrumpRx Fertility program. As the Trump Administration continues to establ...
Morgan Stanley analyst Erin Wright maintains CVS Health (NYSE:CVS) with a Overweight and raises the price target from $82 to...
Goldman Sachs analyst Scott Fidel initiates coverage on CVS Health (NYSE:CVS) with a Buy rating and announces Price Target ...
The stock market stumbled Friday after President Donald Trump threatened a sweeping increase in tariffs on Chinese imports, sen...
Confluent explores a sale, Rothschild exits The Economist, Helsing buys Blue Ocean, Zimmer expands robotics, and Omnicare files...
